Publication | Closed Access

Fecal metabolome profiling of liver cirrhosis and hepatocellular carcinoma patients by ultra performance liquid chromatography–mass spectrometry

HepatologyHepatocellular Carcinoma PatientsMedicineLiver PhysiologyMass SpectrometryFecal Metabolome ProfilingPathologyLiver CirrhosisMetabolomic ProfilingLiver DiseaseLiver CancerMetabolic ProfilingMetabolomicsLiverPharmacologyHepatocellular Carcinoma